Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion type Assertion NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_head.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion description "[The cytokine LIGHT activates various anti-tumor functions through its two receptors, lymphotoxin beta receptor (LTbetaR) and herpes virus entry mediator (HVEM), and is expected to be a promising candidate for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion evidence source_evidence_literature NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion SIO_000772 20117833 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion wasDerivedFrom befree-20140225 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.
- NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_assertion wasGeneratedBy ECO_0000203 NP419180.RARwf66dh6D4u9rYAWwWqA-RjAeCmprf7O1poGECY7kfI130_provenance.